Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM, CAPACITY Study Group

Open source

DOI
10.1016/s0140-6736(11)60405-4
Published
2011 May 21
Container
Lancet (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-11-60405-4,
  title = {Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.},
  author = {Noble PW and Albera C and Bradford WZ and Costabel U and Glassberg MK and Kardatzke D and King TE Jr and Lancaster L and Sahn SA and Szwarcberg J and Valeyre D and du Bois RM and CAPACITY Study Group},
  year = {2011},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(11)60405-4},
  url = {https://doi.org/10.1016/s0140-6736(11)60405-4}
}

RIS

TY  - JOUR
TI  - Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
AU  - Noble PW
AU  - Albera C
AU  - Bradford WZ
AU  - Costabel U
AU  - Glassberg MK
AU  - Kardatzke D
AU  - King TE Jr
AU  - Lancaster L
AU  - Sahn SA
AU  - Szwarcberg J
AU  - Valeyre D
AU  - du Bois RM
AU  - CAPACITY Study Group
PY  - 2011
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(11)60405-4
UR  - https://doi.org/10.1016/s0140-6736(11)60405-4
ER  - 

APA

PW, N., C, A., WZ, B., U, C., MK, G., D, K., Jr, K. T., L, L., SA, S., J, S., D, V., RM, D. B., & Group, C. S. (2011). Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(11)60405-4

Source records